niacinamide has been researched along with Atherogenesis in 7 studies
nicotinamide : A pyridinecarboxamide that is pyridine in which the hydrogen at position 3 is replaced by a carboxamide group.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Atherosclerosis is identified as the formation of atherosclerotic plaques, which could initiate the formation of a blood clot in which its growth to coronary artery can lead to a heart attack." | 2.58 | N1-methylnicotinamide (MNAM) as a guardian of cardiovascular system. ( Fattahi, A; Jodati, AR; Latifi, Z; Mihanfar, A; Nejabati, HR; Nouri, M; Pezeshkian, M; Safaie, N; Valiloo, M, 2018) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (14.29) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (14.29) | 29.6817 |
| 2010's | 4 (57.14) | 24.3611 |
| 2020's | 1 (14.29) | 2.80 |
| Authors | Studies |
|---|---|
| Olaniyi, KS | 1 |
| Amusa, OA | 1 |
| Akinnagbe, NT | 1 |
| Ajadi, IO | 1 |
| Ajadi, MB | 1 |
| Agunbiade, TB | 1 |
| Michael, OS | 1 |
| Nakatsu, Y | 1 |
| Kokubo, H | 1 |
| Bumdelger, B | 1 |
| Yoshizumi, M | 1 |
| Yamamotoya, T | 1 |
| Matsunaga, Y | 1 |
| Ueda, K | 1 |
| Inoue, Y | 1 |
| Inoue, MK | 1 |
| Fujishiro, M | 1 |
| Kushiyama, A | 1 |
| Ono, H | 1 |
| Sakoda, H | 1 |
| Asano, T | 1 |
| Nejabati, HR | 1 |
| Mihanfar, A | 1 |
| Pezeshkian, M | 1 |
| Fattahi, A | 1 |
| Latifi, Z | 1 |
| Safaie, N | 1 |
| Valiloo, M | 1 |
| Jodati, AR | 1 |
| Nouri, M | 1 |
| Mateuszuk, L | 1 |
| Jasztal, A | 1 |
| Maslak, E | 1 |
| Gasior-Glogowska, M | 1 |
| Baranska, M | 1 |
| Sitek, B | 1 |
| Kostogrys, R | 1 |
| Zakrzewska, A | 1 |
| Kij, A | 1 |
| Walczak, M | 1 |
| Chlopicki, S | 1 |
| Jiang, N | 1 |
| Wang, M | 1 |
| Song, J | 1 |
| Liu, Y | 1 |
| Chen, H | 1 |
| Mu, D | 1 |
| Xia, M | 1 |
| CASTELLO, S | 1 |
| SALVATORE, V | 1 |
| Kalia, R | 1 |
| Rao, CM | 1 |
| Kutty, NG | 1 |
1 review available for niacinamide and Atherogenesis
| Article | Year |
|---|---|
N1-methylnicotinamide (MNAM) as a guardian of cardiovascular system.
Topics: Atherosclerosis; Cardiovascular System; Coronary Artery Disease; Epoprostenol; Humans; Lipid Droplet | 2018 |
6 other studies available for niacinamide and Atherogenesis
| Article | Year |
|---|---|
Acetate ameliorates nephrotoxicity in streptozotocin-nicotinamide-induced diabetic rats: Involvement of xanthine oxidase activity.
Topics: Alanine Transaminase; Animals; Aspartate Aminotransferases; Atherosclerosis; Blood Glucose; Choleste | 2021 |
The SGLT2 Inhibitor Luseogliflozin Rapidly Normalizes Aortic mRNA Levels of Inflammation-Related but Not Lipid-Metabolism-Related Genes and Suppresses Atherosclerosis in Diabetic ApoE KO Mice.
Topics: Animals; Aorta; Apolipoproteins E; Atherosclerosis; Cell Adhesion Molecules; Cytokines; Diabetes Mel | 2017 |
Antiatherosclerotic Effects of 1-Methylnicotinamide in Apolipoprotein E/Low-Density Lipoprotein Receptor-Deficient Mice: A Comparison with Nicotinic Acid.
Topics: Animals; Aorta; Apolipoproteins E; Atherosclerosis; Female; Mice; Mice, Inbred C57BL; Mice, Knockout | 2016 |
N-methylnicotinamide protects against endothelial dysfunction and attenuates atherogenesis in apolipoprotein E-deficient mice.
Topics: Acetylcholine; Amidohydrolases; Animals; Aorta; Arginine; Atherosclerosis; Cholesterol, Dietary; Cyc | 2016 |
[Action of a gastric mucin preparation and various vitamins on the most indicative hematochemical indices of atherosclerosis].
Topics: Arteriosclerosis; Ascorbic Acid; Atherosclerosis; Cholesterol; Gastric Mucins; Humans; Lipids; Niaci | 1963 |
Synthesis and evaluation of the antiinflammatory activity of N-[2-(3,5-di-tert-butyl-4-hydroxyphenyl)-4-oxo-thiazolidin-3-yl]-nicotinamide.
Topics: Alanine Transaminase; Animals; Anti-Inflammatory Agents, Non-Steroidal; Antioxidants; Arthritis, Exp | 2007 |